You are here: Industry Insights > CDMO

News List

Chime Biologics announces Marc Funk as new Board Director prnasia
March 22, 2021
Chime Biologics is pleased to announce the appointment of Marc Funk to its Board of Directors. Marc brings more than 20 years of leadership and industry experience in the global CDMO space.
Alcami Names Patrick D. Walsh as Chairman and CEO contractpharma
March 22, 2021
Alcami, a global pharmaceutical CDMO, has appointed Patrick D. Walsh as chairman and chief executive officer, effective immediately. He succeeds Walter J. Kaczmarek III, who is stepping down as chief executive.
Fujifilm Selects North Carolina for $2B Bio CDMO Facility contractpharma
March 22, 2021
Fujifilm Corporation said it has selected Holly Springs, NC as the location for its new large-scale cell culture production site in the U.S.
ANI Pharmaceuticals Strengthens CDMO Biz contractpharma
March 12, 2021
ANI Pharmaceuticals has struck a $163.5 million deal to acquire Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities.
Altasciences Doubles Size of PA CDMO Facility contractpharma
March 11, 2021
The additional 35,000-sq.-ft. building in Philadelphia will include warehouse and cGMP manufacturing suites.
Charles River Acquires CDMO Cognate BioServices contractpharma
February 18, 2021
Charles River Laboratories has signed an agreement to acquire Cognate BioServices, a cell and gene therapy contract development and manufacturing organization (CDMO), for approximately $875 million.
Wacker Strengthens Biologics Business contractpharma
February 05, 2021
The Munich, Gemany-based chemical company Wacker is acquiring 100 percent of the shares in pharmaceutical contract manufacturer Genopis from South Korea-based firms Helixmith and Medivate Partners.
MedPharm Launches Scientific Advisory Committee contractpharma
February 05, 2021
MedPharm Ltd, a contract service provider of contract topical and transdermal product design and formulation development services, has launched its Scientific Advisory Committee, headed by company founder and Board member, professor Marc Brown.
Metrics Contract Services Appoints BD VP contractpharma
February 04, 2021
Metrics Contract Services, a full-service contract development and manufacturing organization (CDMO) in novel oral solid dose products, has appointed Britton Jimenez as vice president of business development.
Frontida Expands Testing Capabilities contractpharma
February 03, 2021
Frontida BioPharm has launched its new Category 1 (CAT.ONE) in vitro testing and evaluation services to support development and regulatory approvals for abuse-deterrent formulations of pain management and Central Nervous System (CNS) targeted therapies.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page